Not sure where to start? Try searching for your diagnosis above or visit the "Conditions" section.
4 items
The FDA granted Fast Track designation to a new CAR-T therapy targeting multiple autoimmune diseases, signaling potential for faster develop...
View — FDA Grants Fast Track Status to New CAR-T Therapy for Lupus, Myositis, and Scleroderma »Imviva Biotech's CTA313, an off-the-shelf CAR-T cell therapy for lupus and other B-cell driven autoimmune diseases, has received FDA clearan...
View — A CAR-T for Lupus Clears the FDA »Lupus Canada is funding a new study using a non-invasive brain-imaging technique to understand cognitive dysfunction in childhood-onset lupu...
View — Funding a Closer Look at Lupus Brain Fog in Kids »